Bavarian Nordic is abandoning its Covid-19 booster vaccine after Phase III results — even though it did hit the primary endpoint of the study — because it’s not as effective against newer variants of the virus.
https://endpts.com/bavarians-covid-booster-not-a-commercial-opportunity-after-data-show-its-not-as-effective-against-new-variants/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.